Sotera Health (SHC) just unveiled an announcement.
Sotera Health Company expanded its Board of Directors by adding Christopher A. Simon, a seasoned executive with a rich background in medical technology and strategic consulting, effective August 1, 2024. Simon brings to the table his experience as President and CEO of Haemonetics Corporation, previous senior partnership at McKinsey & Company, and his military service as a U.S. Army Infantry Officer. His induction is backed by an indemnification agreement and follows Nasdaq’s independence rules, ensuring no conflicts of interest or undisclosed arrangements affect his appointment. Simon’s compensation aligns with the company’s policy for non-employee directors.
Find detailed analytics on SHC stock on TipRanks’ Stock Analysis page.
